Sironax Switzerland GmbH
ActiveLimited Liability Company721001 - Research and experimental development in the pharmaceutical industrysironax.com
BiotechnologyPatients with neurodegenerative, inflammatory, immunologic, and metabolic diseases.
Sironax Switzerland GmbH is a Swiss GmbH registered in Allschwil, BL. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~23 employees (globally)RevenueUSD 2,000,000 annuallyOfficers4Active Relations4Deleted Relations0SOGC Records1First Record26.06.2025Latest Activity01.07.2025BiotechnologyNeurodegenerationSmall moleculesBrain deliveryClinical-stage
Registry Information
c/o address
- Swiss UID
- CHE-487.401.538
- Legal Name
- Sironax Switzerland GmbH
- Legal Form
- Limited liability company
- Incorporated
- 19 May 2025
- Share Capital
- CHF 20'000.00
- Canton
- BL
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
c/o Switzerland Innovation Park Basel Area AG
4123, Allschwil, BL
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients with neurodegenerative, inflammatory, immunologic, and metabolic diseases.
Competitors (2)
Evommune
Biotechnology company developing therapies for immune-mediated inflammatory diseases.
Accropeutics
Clinical-stage biotech company specializing in the study of molecular mechanisms related to regulated cell death and its impact on human diseases.
